Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-13 1:50 pm Purchase | 2024-12-31 | 13G | Imunon, Inc. IMNN | Ayrton Capital LLC | 1,250,000 7.900% | 1,250,000 (New Position) | Filing History |
| 2025-02-13 1:47 pm Sale | 2024-12-31 | 13G | Trio Petroleum Corp. TPET | Ayrton Capital LLC | 38,496 0.100% | -199,875 (-83.85%) | Filing History |
| 2025-02-13 1:46 pm Sale | 2024-12-31 | 13G | ToughBuilt Industries, Inc. TBLT | Ayrton Capital LLC | 65,812 4.400% | -4,031,322 (-98.39%) | Filing History |
| 2025-02-13 1:44 pm Sale | 2024-12-31 | 13G | Petros Pharmaceuticals, Inc. PTPI | Ayrton Capital LLC | 657,614 6.200% | -15,296 (-2.27%) | Filing History |
| 2025-02-13 1:42 pm Sale | 2024-12-31 | 13G | PharmaCyte Biotech, Inc. PMCB | Ayrton Capital LLC | 774,100 9.900% | -182,129 (-19.05%) | Filing History |
| 2025-02-13 1:40 pm Purchase | 2024-12-31 | 13G | PAVmed Inc. PAVM | Ayrton Capital LLC | 1,226,316 9.900% | 375,298 (+44.10%) | Filing History |
| 2025-02-13 1:38 pm Sale | 2024-12-31 | 13G | Lucid Diagnostics Inc. LUCD | Ayrton Capital LLC | 1,200,485 2.000% | -3,755,213 (-75.78%) | Filing History |
| 2025-02-13 1:35 pm Sale | 2024-12-31 | 13G | KWESST Micro Systems Inc. KWE | Ayrton Capital LLC | 118,500 7.000% | -1,066,500 (-90.00%) | Filing History |
| 2025-02-13 1:33 pm Unchanged | 2024-12-31 | 13G | SeaStar Medical Holding Corporation ICU | Ayrton Capital LLC | 294,361 6.200% | 0 (Unchanged) | Filing History |
| 2025-02-13 1:32 pm Unchanged | 2024-12-31 | 13G | Genius Group Limited GNS | Ayrton Capital LLC | 1,953,162 8.300% | 0 (Unchanged) | Filing History |
| 2025-02-13 1:23 pm Purchase | 2024-12-31 | 13G | Arcimoto, Inc. FUVV | Ayrton Capital LLC | 945,930 9.900% | 945,930 (New Position) | Filing History |
| 2025-02-13 1:20 pm Unchanged | 2024-12-31 | 13G | China Natural Resources, Inc. CHNR | Ayrton Capital LLC | 557,951 5.400% | 0 (Unchanged) | Filing History |
| 2025-02-13 1:17 pm Purchase | 2024-12-31 | 13G | Addentax Group Corp. ATXG | Ayrton Capital LLC | 646,542 9.900% | 215,139 (+49.87%) | Filing History |
| 2025-02-13 1:14 pm Purchase | 2024-12-31 | 13G | Tritium DCFC Limited DCFC | Ayrton Capital LLC | 18,777,000 9.900% | 18,685,060 (+20323.21%) | Filing History |
| 2025-02-13 1:11 pm Purchase | 2024-12-31 | 13G | Ocean Biomedical, Inc. OCEA | Ayrton Capital LLC | 3,873,632 9.900% | 91,866 (+2.43%) | Filing History |
| 2025-02-13 1:07 pm Purchase | 2024-12-31 | 13G | Traws Pharma, Inc. TRAW | Ayrton Capital LLC | 403,650 9.900% | 403,650 (New Position) | Filing History |
| 2025-02-13 1:05 pm Purchase | 2024-12-31 | 13G | The Glimpse Group, Inc. VRAR | Ayrton Capital LLC | 1,860,380 9.900% | 1,860,380 (New Position) | Filing History |
| 2025-02-13 1:03 pm Purchase | 2024-12-31 | 13G | Sidus Space, Inc. SIDU | Ayrton Capital LLC | 724,638 8.400% | 724,638 (New Position) | Filing History |
| 2025-02-13 1:01 pm Purchase | 2024-12-31 | 13G | 180 Life Sciences Corp. ATNF | Ayrton Capital LLC | 334,742 9.900% | 334,742 (New Position) | Filing History |
| 2024-11-14 5:37 pm Purchase | 2024-09-30 | 13G | Imunon, Inc. CLSN | Ayrton Capital LLC | 1,054,438 9.900% | 684,068 (+184.70%) | Filing History |